Mod­er­na, IBM turn to quan­tum com­put­ing in hunt for new mR­NA med­i­cines

Mod­er­na plans to build a “quan­tum-ready work­force,” in CEO Stéphane Ban­cel’s words, with the help of glob­al tech con­glom­er­ate IBM, the com­pa­nies said Thurs­day morn­ing.

As the Cam­bridge, MA-based biotech ex­pands be­yond Covid-19 vac­cines and in­to flu, RSV and oth­er dis­ease ar­eas, Mod­er­na plans to em­ploy quan­tum com­put­ing and gen­er­a­tive AI to make new mR­NA med­i­cines, op­ti­mize lo­gis­tics and do what a “clas­si­cal com­put­er” can’t. Gen­er­a­tive AI is now din­ner-par­ty fod­der thanks to the ar­rival of Chat­G­PT late last year.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN